Complete remission of minimal-change nephrotic syndrome induced by apheresis monotherapy

Clinical Nephrology

Volumn 65, Issue 6, 2006, Pages 423-426

  Kobayashi, T ^a   Ando, Y ^a   Umino, T ^a   Miyata, Y ^a   Muto, S ^a   Hironaka, M ^a   Asano, Y ^a   Kusano, E ^a  

^a JICHI MEDICAL UNIVERSITY   (Japan)

Author keywords

Apheresis monotherapy; Complete remission; Double filtration plasmapheresis (DFPP); Low density lipoprotein apheresis (LDL A); Minimal change nephrotic syndrome (MCNS)

Indexed keywords

ALANINE AMINOTRANSFERASE; ALBUMIN; ALKALINE PHOSPHATASE; ASPARTATE AMINOTRANSFERASE; BILIRUBIN; CALCIUM; CHLORIDE; CHOLESTEROL; CREATININE; GLUCOCORTICOID; HEMOGLOBIN; HEPATITIS B(E) ANTIBODY; HEPATITIS B(E) ANTIGEN; IMMUNOGLOBULIN A; IMMUNOGLOBULIN G; IMMUNOGLOBULIN M; LACTATE DEHYDROGENASE; LOW DENSITY LIPOPROTEIN; LOW DENSITY LIPOPROTEIN CHOLESTEROL; NITROGEN; PHOSPHATE; POTASSIUM; PREDNISOLONE; SODIUM; TRIACYLGLYCEROL; UREA; VIRUS DNA;

ADOLESCENT; ALANINE AMINOTRANSFERASE BLOOD LEVEL; APHERESIS; ARTICLE; ASPARTATE AMINOTRANSFERASE BLOOD LEVEL; CASE REPORT; CREATININE BLOOD LEVEL; DISEASE EXACERBATION; DRUG WITHDRAWAL; ELECTROLYTE BLOOD LEVEL; ERYTHROCYTE COUNT; FOLLOW UP; GENERALIZED EDEMA; HEMATOCRIT; HEPATITIS B VIRUS; HUMAN; HUMAN TISSUE; IMMUNOGLOBULIN BLOOD LEVEL; KIDNEY BIOPSY; LIVER DYSFUNCTION; MALE; NEPHROTIC SYNDROME; PLASMAPHERESIS; PROTEINURIA; RELAPSE; REMISSION; THROMBOCYTE COUNT; UREA NITROGEN BLOOD LEVEL; URINALYSIS; VIRUS CARRIER;

EID: 33744962695     PISSN: 03010430     EISSN: None     Source Type: Journal    
DOI: 10.5414/CNP65423     Document Type: Article

References (12)

1. Akimoto T, Ando Y, Ito C, Muto S, Kusano E, Asano Y. Effect of plasmapheresis as initial monotherapy in a case of anti-neutrophil cytoplasmic autoantibody positive crescentic glomerulonephritis. ASAIO J. 1999; 45: 509-513.
2. Candiano G, Musante L, Carraro M, Faccini L, Campanacci L, Zennaro C, Artero M, Ginevri F, Perfumo F, Gusmano R, Ghiggeri GM. Apolipoproteins prevent glomerular albumin permeability induced in vitro by serum from patients with focal segmental glomerulosclerosis. J Am Soc Nephrol. 2001; 12: 143-150.
3. Garin EH, Blanchard DK, Matsushima K, Djeu JY. IL-8 production by peripheral blood mononuclear cells in nephrotic patients. Kidney Int. 1994; 45: 1311-1317.
4. Koyama A, Fujisaki M, Kobayashi M, Igarashi M, Narita M. A glomerular permeability factor produced by human T cell hybridomas. Kidney Int. 1991; 40: 453-460.
5. Matsumoto K, Kanmatsuse K. Elevated vascular endothelial growth factor levels in the urine of patients with minimal-change nephrotic syndrome. Clin Nephrol. 2001; 55: 269-274.
6. McCarthy ET, Sharma R, Sharma M. Protective effect of 20-Hydroxyeicosatetraenoic acid (20-HETE) on glomerular protein permeability barrier. Kidney Int. 2005; 67: 152-156.
7. Muso E, Mune M, Fujii Y, Imai E, Ueda N, Hatta K, Imada A, Takemura T, Miki S, Kuwahara T, Takamitsu Y, Tsubakihara Y, Kansai FGS LDL Apheresis Treatment (K-FLAT) Study Group. Significantly rapid relief from steroid-resistant nephrotic syndrome by LDL apheresis compared with steroid monotherapy. Nephron. 2001; 89: 408-415.
8. Okada T, Takahashi H, Ogura M, Nakao T, Shimizu T. Complete remisson of steroid-resistant minimal-change nephrotic syndrome by cyclosporine after additional low-density lipoprotein apheresis treatment. Jpn J Nephrol. 1996; 38: 46-51.
9. Savin VJ, Sharma R, Sharma M, McCarthy ET, Swan SK, Ellis E, Lovell H, Warady B, Gunwar S, Chonko AM, Artero M, Vincenti F. Circulating factor associated with increased glomerular permeability to albumin in recurrent focal segmental glomerulosclerosis. N Engl J Med. 1996; 334: 878-883.
10. Yap HK, Cheung W, Murugasu B, Sim SK, Seah CC, Jordan SC. Th1 and Th2 cytokine mRNA profiles in childhood nephrotic syndrome: evidence for increased IL-13 mRNA expression in relapse. J Am Soc Nephrol. 1999; 10: 529-537.
11. Yokoyama K, Sakai S, Yamaguchi Y, Suzuki Y, Hinoshita F, Hara S, Yamada A, Ogura Y, Kawaguchi Y, Sakai O. Complete remission of the nephrotic syndrome due to focal glomerular sclerosis achieved with low density lipoprotein adsorption alone. Nephron. 1996; 72: 318-320.
12. Yokoyama K, Sakai S, Sigematsu T, Takemoto F, Hara S, Yamada A, Kawaguchi Y, Hosoya T. LDL adsorption improves the response of focal glomerulosclerosis to corticosteroid therapy. Clin Nephrol. 1998; 50: 1-7.